Acceptability of the reusable SurePal™ self-injection device for Omnitrope® among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study

Acceptability of the reusable SurePal™ self-injection device for Omnitrope® among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study

Carl-Joachim Partsch,1 Dirk Schnabel,2 Sarah Ehtisham,3 Helen C Johnstone,4 Markus Zabransky,5 Wieland Kiess61Endokrinologikum Hamburg, Hamburg, 2Division of Endocrinology and Diabetology, Otto-Heubner-Center for Pediatric and Adolescent Medicine, Charité University, Berlin, Germany; 3Cen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Partsch CJ, Schnabel D, Ehtisham S, Johnstone HC, Zabransky M, Kiess W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Medical technology
R855-855.5
Acceso en línea:https://doaj.org/article/d63ab23d52b3473499dac43e0fcd536e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares